SEC Form 4 · accession 0001140361-15-045632
BioRestorative Therapies, Inc. · BRTX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Mark Weinreb
Officer — CEO and Chairman of the Board · Director · 10% Owner
Period of report
Dec 22, 2015
Accepted (ET)
Dec 28, 2015 · 11:16 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001505497
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | holding | — | — | — | 85,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionF6,F7 | $7.00 | Dec 22, 2015 | A | 208,000 | A | — | Sep 4, 2025 | Common Stock | 208,000 | 208,000 | D |
| Stock Option | $10.00 | holding | — | — | — | Dec 15, 2010 | Dec 14, 2020 | Common Stock | 4,000 | 4,000 | D |
| Stock OptionF1 | $21.00 | holding | — | — | — | — | Feb 9, 2022 | Common Stock | 50,000 | 50,000 | D |
| Stock OptionF2 | $30.00 | holding | — | — | — | — | Dec 7, 2022 | Common Stock | 20,000 | 20,000 | D |
| Stock OptionF3 | $12.00 | holding | — | — | — | — | Oct 4, 2023 | Common Stock | 12,500 | 12,500 | D |
| Stock OptionF4 | $13.00 | holding | — | — | — | — | Feb 18, 2024 | Common Stock | 50,000 | 50,000 | D |
| Stock OptionF5 | $6.60 | holding | — | — | — | — | Oct 23, 2024 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1The option is exercisable to the extent of 16,667 shares on each of February 10, 2012 and February 10, 2013 and 16,666 shares on February 10, 2014.
- F2The option is exercisable to the extent of 10,000 shares on each of December 7, 2012 and December 7, 2013.
- F3The option is exercisable to the extent of 6,250 shares on each of October 4, 2013 and October 4, 2014.
- F4The option is exercisable to the extent of 16,667 shares on each of February 18, 2014 and February 18, 2015 and 16,666 shares on February 18, 2016.
- F5The option is exercisable to the extent of 50,000 shares on each of October 23, 2015, October 23, 2016 and October 23, 2017.
- F6On December 22, 2015, the stockholders of the Issuer approved amendments to the Issuer's 2010 Equity Participation Plan (the "Plan") to increase the number of shares authorized to be issued pursuant to the Plan to 2,250,000. The Reporting Person had been granted the option on September 4, 2015, subject to stockholder approval of such amendments.
- F7The option is exercisable to the extent of 104,000 shares on December 22, 2015, 34,667 shares on each of September 4, 2016 and September 4, 2017, and 34,666 shares on September 4, 2018.